Scott F. Sneddon
Directeur Général chez Sharp Edge Labs, Inc.
Profil
Scott F.
Sneddon is currently the President, Chief Executive & Scientific Officer at Sharp Edge Labs, Inc. He previously worked as a Senior Director at Genzyme Corp.
and as a Research Scientist & Group Leader at Pfizer Inc. Dr. Sneddon holds a doctorate degree from Carnegie Mellon University and a graduate degree from The Trustees of Columbia University in The City of New York.
Postes actifs de Scott F. Sneddon
| Sociétés | Poste | Début |
|---|---|---|
Sharp Edge Labs, Inc.
 Sharp Edge Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Sharp Edge Labs, Inc. develops biosensors to the cellular biology research community. It operates as a assay development company that offers products and services for drug discovery. The firm offers fluorogenic activating protein, which provides accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and detailed follow-up. The company was founded by Alan S. Waggoner and Marcel P. Bruchez in 2010 and is headquartered in Pittsburgh, PA. | Directeur Général | - |
Anciens postes connus de Scott F. Sneddon
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
| PFIZER, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Scott F. Sneddon
| Carnegie Mellon University | Doctorate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sharp Edge Labs, Inc.
Sharp Edge Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Sharp Edge Labs, Inc. develops biosensors to the cellular biology research community. It operates as a assay development company that offers products and services for drug discovery. The firm offers fluorogenic activating protein, which provides accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and detailed follow-up. The company was founded by Alan S. Waggoner and Marcel P. Bruchez in 2010 and is headquartered in Pittsburgh, PA. | Commercial Services |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
